IPO Profile

Targacept Inc.
200 East First Street, Suite 300, Winston-Salem, North Carolina 27101
Tel: 336-480-2100
Web: www.targacept.com
Ticker: TRGT
Stock Exchange: Nasdaq
Shares Issued: 0.00
Price Offered: $0.00
Amount Raised: $86,250,000.00

Underwriters:
Morgan Stanley & Co.
Deutsche Bank Securities
CIBC World Markets
Pacific Growth Equities


Company Description:
We are a biopharmaceutical company engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting neuronal nicotinic acetylcholine receptors, or NNRs. NNRs are found on nerve cells throughout the nervous system and serve as key regulators of nervous system activity. Our product candidates are designed to selectively target specific NNR subtypes to promote therapeutic effects while limiting or eliminating adverse side effects. In addition to a marketed product, Inversine, we have four product candidates in clinical development and multiple ongoing preclinical programs.